University of Chicago Medical Center /ID# 276638

Chicago, Illinois 60637

1 studies enrolling now · 1 studies all time

What they study most

Advanced Squamous Tumors

Studies at this site

• A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors — Recruiting now